Cano Health Inc (OTCPK:CANOQ)

$ 0.33 0.0545 (19.78%) Market Cap: 1.57 Mil Enterprise Value: 1.22 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 28/100

Q3 2023 Cano Health Inc Earnings Call Transcript
Nov 09, 2023

$8.22 (-7.54%)

Earnings
Cano Health Inc Extraordinary Shareholders Meeting Transcript
Nov 02, 2023
Q2 2023 Cano Health Inc Earnings Call Transcript
Aug 10, 2023

$152 (-0.65%)

Earnings
Cano Health Inc Annual Shareholders Meeting Transcript
Jun 15, 2023
Q1 2023 Cano Health Inc Earnings Call Transcript
May 09, 2023

$105 (-6.25%)

Earnings
Cano Health Inc at Cowen Health Care Conference Transcript
Mar 06, 2023
Q4 2022 Cano Health Inc Earnings Call Transcript
Mar 01, 2023

$157 (-4.85%)

Earnings
Q3 2022 Cano Health Inc Earnings Call Transcript
Nov 09, 2022

$334 (-4.84%)

Earnings
Cano Health Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2022
Q2 2022 Cano Health Inc Earnings Call Transcript
Aug 09, 2022

$546 (-9.90%)

Earnings
Cano Health Inc To Host Investor Day Transcript
Jun 07, 2022
Cano Health Inc at UBS Global Healthcare Conference Transcript
May 23, 2022
Cano Health Inc at Bank of America Healthcare Conference Transcript
May 12, 2022
Q1 2022 Cano Health Inc Earnings Call Transcript
May 09, 2022

$438 (-8.94%)

Earnings
Q4 2021 Cano Health Inc Earnings Call Transcript
Mar 14, 2022

$531 (-10.30%)

Earnings
Cano Health Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 11, 2022
Q3 2021 Cano Health Inc Earnings Call Transcript
Nov 09, 2021

$1240 (+11.31%)

Earnings

Cano Health Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2022 / 08:05PM GMT

Release Date Price: $640 (-4.05%)

Transcript

Hua Ha

Morgan Stanley, Research Division - Equity Analyst

Hi. Welcome, everyone. My name is Michael Ha, a Managed Care and Healthcare Services analyst at Morgan Stanley. Our next session is with Cano Health, one of the largest providers of physician services through its capitated physician clinic model. I'm pleased to have with us today Chairman and CEO, Dr. Marlow Hernandez; and Chief Financial Officer, Brian Koppy.

Before I get started, I'll read the research disclosure. For important disclosures, please see the Morgan Stanley Research Disclosure Website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales rep. And with that, would you like to make any introductory remarks or jump right into the Q&A?

Marlow Hernandez Cano

Cano Health, Inc. - Founder, CEO, President & Chairman of the Board

Let's jump right in, Mike. Thank you for the invitation.

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.